MKI67 and neuroendocrine carcinoma: The 2019 WHO classification of digestive tumours separated these tumours into two different disease entities: well-differentiated neuroendocrine tumours with a Ki-67 > 20% (NET G3) and poorly differentiated neuroendocrine carcinomas (NEC) [1].